In conclusion, we identified, according to several data in literature, the key role of NADPH oxidase in the development of DN complications, giving new insight into its mechanism of action, which contributes to vascular and functional diseases in type-2 diabetes. This evidence concerns the gene FMO5 and liver dysplastic nodule.